Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Rosti

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|March 2, 2023
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell TumorsGiuseppe Schepisi, Caterina Gianni, Maria Concetta Cursano, et al.
Bone Marrow Transplantation|January 26, 2018
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: a 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT)Andrea Necchi, Salvatore Lo Vullo, Simona Secondino, et al.
Frontiers in Oncology|April 11, 2024
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature reviewDiletta Favero, Christoph Oing, Christoph Seidel, et al.
International Journal of Cancer|January 6, 2010
Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experienceJacques-Olivier Bay, Aurélie Cabrespine-Faugeras, Reza Tabrizi, et al.
Nature Clinical Practice. Oncology|April 10, 2008
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumorsTaner Demirer, Lisbeth Barkholt, Didier Blaise, et al.
The Oncologist|December 21, 2020
Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not DeferrablePaolo Pedrazzoli, David Rondonotti, Carlo Cattrini, et al.
Future Oncology (London, England)|March 19, 2019
Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical managementChiara Casadei, Giuseppe Schepisi, Cecilia Menna, et al.
International Journal of Molecular Sciences|June 2, 2021
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic ReviewGiuseppe Schepisi, Caterina Gianni, Sara Bleve, et al.
Therapeutic Advances in Medical Oncology|February 17, 2017
Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective studyGiovanni Rosti, Mario Petrini, Alberto Bosi, et al.
Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|March 2, 2023
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell TumorsGiuseppe Schepisi, Caterina Gianni, Maria Concetta Cursano, et al.
Bone Marrow Transplantation|January 26, 2018
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: a 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT)Andrea Necchi, Salvatore Lo Vullo, Simona Secondino, et al.
Frontiers in Oncology|April 11, 2024
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature reviewDiletta Favero, Christoph Oing, Christoph Seidel, et al.
International Journal of Cancer|January 6, 2010
Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experienceJacques-Olivier Bay, Aurélie Cabrespine-Faugeras, Reza Tabrizi, et al.
Nature Clinical Practice. Oncology|April 10, 2008
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumorsTaner Demirer, Lisbeth Barkholt, Didier Blaise, et al.
The Oncologist|December 21, 2020
Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not DeferrablePaolo Pedrazzoli, David Rondonotti, Carlo Cattrini, et al.
Future Oncology (London, England)|March 19, 2019
Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical managementChiara Casadei, Giuseppe Schepisi, Cecilia Menna, et al.
International Journal of Molecular Sciences|June 2, 2021
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic ReviewGiuseppe Schepisi, Caterina Gianni, Sara Bleve, et al.
Therapeutic Advances in Medical Oncology|February 17, 2017
Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective studyGiovanni Rosti, Mario Petrini, Alberto Bosi, et al.
Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.
Pageof 9